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Mutation in the Mismatch Repair Gene Msh6
Causes Cancer Susceptibility
eukaryotic systems have enzymatic systems that cor-
rect DNA mismatches. Of particular interest is the bacte-
rial MutHLS system and its counterpart in eukaryotic
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cells. The bacterial system repairs single-base mis-Michael F. Kane,7,8 James R. Lipford,7
matches and small insertion/deletions in DNA (for re-Nianjun Yu,9 Gray F. Crouse,9
views see Modrich, 1991; Kolodner et al., 1995, 1996;Jeffrey W. Pollard,4 Thomas Kunkel,6
Modrich and Lahue, 1996). Genetic and biochemicalMartin Lipkin,5 Richard Kolodner,7,8
studies in eukaryotic systems have revealed that theyand Raju Kucherlapati2
have a mismatch repair system similar to the bacterial1Department of Cell Biology
MutHLS system (for reviews, see Kolodner et al., 1995,2Department of Molecular Genetics
1996; Modrich and Lahue, 1996), although more complex.3Department of Pathology
Families of genes that share homology to the bacterial4Department of Developmental and Molecular Biology
mutS and are therefore referred to as mutS homologsAlbert Einstein College of Medicine
(MSH) and mutL homologs (MLH) have been identifiedBronx, New York 10461
in yeast and mammalian cells as well as other organisms.5Strang Cancer Research Laboratory
Six MSH genes (MSH1±MSH6) and four MLH genesThe Rockefeller University
(MLH1±MLH3, PMS1) have been described in yeast, andNew York, New York 10021
many such genes have been described in mammalian6National Institute of Environmental
cells and other organisms. Interest in the mismatch re-Health Sciences
pair genes was significantly enhanced by the discoveryNational Institutes of Health
that germline mutations in some of the mismatch repairResearch Triangle Park, North Carolina 27709
genes leads toa geneticpredisposition for colon cancer,7Dana Farber Cancer Center
referred to as hereditary nonpolyposis colon cancerBoston, Massachusetts 02115
(HNPCC, Fishel et al., 1993; Leach et al., 1993; Bronner8Ludwig Institute for Cancer Research
et al., 1994; Papadopoulos et al., 1994; Fishel and Ko-La Jolla, California 92093
lodner, 1995). HNPCC is one of the common cancer9Emory University
susceptibility syndromes that is inherited in an autoso-Atlanta, Georgia 30322
mal-dominant fashion. A large proportion of HNPCC
family members develop colonic, endometrial, and ovar-
ian tumors as well as tumors at other sites. The tumors
are characterized by a high level of genomic instability,Summary
usually observed as changes in repeat numbers of
mono- and dinucleotide repeat loci. Germline mutationsMice carrying a null mutation in the mismatch repair
in MSH2 and MLH1 are the most common amonggene Msh6 were generated by gene targeting. Cells
HNPCC kindreds, whereas only 1 mutation in PMS1 andthat were homozygous for the mutation did not pro-
2 mutations in PMS2 have been described (Kolodner etduce any detectable MSH6 protein, and extracts pre-
al., 1994; Nicolaides et al., 1994; Liu et al., 1996; Pelto-pared from these cells were defective for repair of
maki et al., 1997).single nucleotide mismatches. Repair of 1, 2, and 4
Biochemical studies revealed that a complex of pro-nucleotide insertion/deletion mismatches was unaf-
teins recognize and bind to mismatches in yeast andfected. Mice that were homozygous for the mutation
mammalian cells. These studies have shown that MSH2had a reduced life span. The mice developed a spec-
is capable of forming a complex with MSH3 or MSH6trum of tumors, the most predominant of which were
(Drummond et al., 1995; Acharya et al., 1996; Habrakengastrointestinal tumors and B- as well as T-cell lym-
et al., 1996; Marsischky et al., 1996; Palombo et al.,phomas. The tumors did not show any microsatellite
1996) and that each of these complexes appears to haveinstability. We conclude that MSH6 mutations, like
a different mispair recognition specificity. It has alsothose in some other members of the family of mis-
been suggested, based on yeast genetic experiments,match repair genes, lead to cancer susceptibility, and
that MSH3 and MSH6 may at least partially substitutegermline mutations in this gene may be associated
for each other, thus accounting for the strong, generalwith a cancer predisposition syndrome that does not
mutator phenotypes of MSH2 mutants and the distinct,show microsatellite instability.
partially overlapping mutator phenotypes of MSH3 and
MSH6 mutants (Johnson et al., 1996; Marsischky et al.,
Introduction 1996; Sia et al., 1997). The genetic studies performed
to date (Marsischky et al., 1996; Sia et al., 1997) support
Mismatches in DNA may result from errors in DNA repli- the view that the MSH2±MSH6 complex functions in the
cation, genetic recombination, and chemical modifica- repair of single base-base mispairs and smaller inser-
tion of DNA and DNA precursors. Both prokaryotic and tion/deletion mispairs. In contrast, the MSH2±MSH3
complex does not function in the repair of single base-
base mispairs but rather functions in the repair of inser-
tion/deletion mispairs and is predominantly responsible10 To whom correspondence should be addressed.
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Figure 1. Structure of Mouse Msh6 Gene
(A) Schematic representation of the structure of the Msh6 gene. The boxes containing the numbers 1±10 represent the individual Msh6 exons.
The size of each exon is given below each exon, and the size of each intron is given above the region between each pair of exons. These
sizes were determined by sequencing each relevant region, except in the case of intron 2 where the size was estimated by PCR analysis. In
the case of exon 1, the size given is the number of nucleotides from the A of the ATG to the splice junction, and in the case of exon 10, the
size given is the number of nucleotides from the splice junction to the G of the TAG.
(B) Sequence of the intron-exon junction regions. Intron sequences are given in uppercase letters, and exon sequences are given in lowercase
letters. The numbers in parentheses correspond to the nucleotide coordinates of the coding sequence present in each exon, assuming that
the A of the ATG is nucleotide 1. In the case of exon 1, the sequence upstream of the ATG is sequence derived from genomic clones that
corresponds to the longest 59-RACE sequence obtained. The complete DNA sequences used to construct this figure have been submitted
to Genbank.
for the repair of the larger insertion/deletion mispairs. Msh2, Mlh1, and Pms2 mutant cell lines (Bhattacharyya
et al., 1994; Shibata et al., 1994; Boyer et al., 1995;The second complex required for mismatch repair in-
volves MLH1 and PMS1 (PMS2 in humans) (Prolla et al., Papadopoulos et al., 1995; Risinger et al., 1995). Be-
cause these cell lines had mutations in other genes, the1994; Li and Modrich, 1995).
To understand the role of the mismatch repair genes, precise role of Gtbp/Msh6 mutations in the onset and
progression of cancer has not been determined.several investigators have initiated efforts to generate
mice with mutations in each of the mismatch repair To understand the role of MSH6, we cloned and char-
acterized the mouse Msh6 gene and developed micegenes. The results from these studies have provided
novel insights into the actions of these gene products. with a null mutation in this gene through gene targeting.
In results presented here, we show that MSH6-deficientMice that are homozygous for mutations in Msh2 are
viable (de Wind et al., 1995; Reitmair et al., 1995) but mice are viable, but homozygous mutant cells show a
single nucleotide mismatch repair defect. Most interest-have a reduced life span (Reitmair et al., 1996), exhibit
genomic instability, and have a predisposition to de- ingly, these mice have a significantly reduced life span
and develop lymphomas, gastrointestinal (GI) tumors,velop lymphomas and colonic tumors. Male mice that
are homozygous for mutations in the Pms2 gene are and a number of other types of tumors in tissues includ-
ing those in the liver, lung, skin, and soft tissues. Oursterile and show abnormal chromosomal synapsis dur-
ing meiosis, while the females are normal (Baker et al., results show that Msh6 mutation causes cancer suscep-
tibility and suggest that mutations in this gene may be1995). Mice with mutations in Mlh1, in the homozygous
state, are sterile due to meiotic abnormalities (Baker et involved in hereditary cancer predisposition syndromes
as well as in some sporadic tumors that do not showal., 1996; Edelmann et al., 1996). Both PMS2- and MLH1-
deficient mice show microsatellite instability in normal microsatellite instability.
tissues (Baker et al., 1995, 1996; Edelmann et al., 1996)
and have predisposition to certain types of cancer Results
(Baker et al 1995; W. E. et al., unpublished data).
The MSH6 gene (also called GTBP and p160) was Isolation and Characterization of the Mouse
Msh6 Geneidentified in mammalian cells through biochemical stud-
ies of mispair binding proteins and biochemical studies Palombo et al. (1995) and Papadopoulos et al. (1995)
described the isolation of the human gene for the 160of a MSH2 complementing activity as well as through
analysis of the yeast genome database. The MSH6 pro- kDa G-T binding protein (GTBP), which is now referred
to as MSH6. The MSH6 gene is in close physical proxim-tein, which is 1358 aa long, was shown to be a part of
the mismatch repair complex (Drummond et al., 1995), ity to MSH2, both of which are located on human chro-
mosome 2 within approximately 1 megabase of eachand mutations in the MSH6 gene were detected in some
tumor cell lines and cell lines selected for resistence to other. The cloning and expression pattern of the mouse
homolog was described by Corradi et al. (1996), whoalkylating agents (Papadopoulos et al., 1995; Risinger
et al., 1996). The MSH6 mutantcell lines had weak micro- also localized the gene to mouse chromosome 17. We
also cloned the mouse Msh6 cDNA and have obtainedsatellite instability at mononucleotide repeats and little
if any dinucleotide repeat instability in contrast to the genomic clones for Msh6 from a mouse genomic P1
library derived from the strain 129/Ola and ascertainedstrong broad spectrum repeat instability observed in
MSH6-Deficient Mice
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Figure 2. Generation of MSH6-Deficient Mice
(A) Gene targeting strategy. Schematic representation of the gene modification strategy. The organization of the wild-type gene, the targeting
construct, and the structure of the locus following gene targeting are shown. Exons are shown as closed boxes. The location of PCR primers
for detecting gene targeting events as well as the expected DraI digestion products that will be recognized by the probe are shown.
(B) Southern blot hybridization of DNA from mice from F2 generation. DNA was digested with DraI and hybridized with probe shown in (A).
The 4.1 kb band corresponds to wild-type, and the 2.5 kb band corresponds to the modified allele. (1/1), wild-type; (1/2), heterozygous;
(2/2), homozygous.
(C) Detection of Msh6 transcript by Northern blot analysis. Total RNA from cell lines of different genotypes was fractionated and blot-hybridized
with the probe shown in Figure 2. A b-actin-specific gene probe was used as a control. (1/1), wild-type; (1/2), heterozygous; (2/2)
homozygous.
(D) Detection of MSH6 protein by Western blotting. Total protein from cells of different genotypes was fractionated, and Western blot analysis
was conducted with an anti-GTBP antibody. The 160 kDa band corresponds to the native MSH6 protein. (1/1), wild-type; (1/2), heterozygous;
(2/2), homozygous.
its genomic structure and determined its pattern of ex- ES cell colonies contained the appropriately modified
Msh6 locus. The targeting event was verified by South-pression.
The deduced genomic structure and the sequences ern blot analysis.
All three of the appropriately targeted cell linesat the intron-exon junctions of the gene are shown in
Figure 1. Northern blot analysis with the mouse Msh6 (MSH6-104, -141 and -147) were injected into blasto-
cysts derived from C57BL/6 females. All of the cell linesprobe revealed a single transcript (4.4 kb) in all mouse
tissues tested (heart, brain, spleen, lung, liver, skeletal yielded mice with high degrees of chimerism, as deter-
mined by coat color, and several of the chimeras derivedmuscle, kidney, and testis), with the highest level of
expression being observed in testis. Corradi et al. (1996) from each of the three cell lines transmitted the modified
chromosome through their germline.detected an Msh6-related sequence on mouse chromo-
some 4, whose functionality is unknown. To rapidly generate cells that are homozygous for
Msh6 gene mutation, we made a gene modification con-
struct that was essentially identical to pMSH6NTK ex-Generation of Mice with a Modified Msh6 Gene
The gene targeting vector and the scheme to generate cept for the replacement of PKGneo with PGKhygro
(pMSH6HTK). Transfection of the pMSH6HTK into MSH6-mice with a mutation in the Msh6 gene is shown in Figure
2. The gene targeting vector, designated pMSH6NTK, 104, a cell line that had one modified copy of Msh6,
yielded several colonies in which both copies of Msh6contained a PGKneo expression cassette inserted into
the Eco47III site in the fourth exon of the gene. This were modified by gene targeting.
site corresponds to codon 336, and sequencing of the
junction revealed that the insertion results in a stop Homozygous Msh6 Mutant Animals Are Viable
To determine the viability of animals that are homozy-codon 21 nucleotides downstream. A correct gene tar-
geting event would result in a truncated protein, if any, gous for the Msh6 mutation, heterozygous F1 mice were
interbred and the F2 offspring genotyped by PCR andand would lack the critical conserved functional motifs
that are located at the COOH end of the normal protein Southern blot analysis. DNA was digested with DraI,
fractionated, and blot hybridized with a probe (Probe A,(Drummond et al., 1995). Therefore, we expected the
targeting event to result in a null mutation. pMSH6NTK Figure 2) corresponding to the 39 end of exon 4 that is not
present in the targeting vector. This probe recognizes awas linearized and introduced into ES cells. We isolated
192 G418- and ganciclovir-resistant ES cell colonies and 4.1 kb fragment from the wild-type allele and a 2.5 kb
fragment from the modified locus. The probe also recog-screened them for the homologous recombination event
by a PCR-based assay. We found that 3 out of the 192 nizes a 4.4 kb band, presumably corresponding to the
Cell
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Figure 4. Survival of Msh6 Mutant Mice
The time of death or the time when mice became moribund was
recorded, and the survival curves were generated by using the Prism
(GraphPad Prism 2.0) software package. The differences between
the 2/2 versus 1/1 and 1/2 curves are significantly different (P ,
Figure 3. Mismatch Repair Efficiency in Extracts from Mouse Cell 0.0001 according to the log rank test).
Lines
Wild-type (1/1), heterozygous (1/2), and homozygous (2/2) Msh6
Extracts of Msh62/2 Cells Have Impairedcell extracts were used to examine the efficiency of repair of sub-
strates containing a G-G mismatch at position 88 or a C-A mismatch Mismatch Repair Activity
at position 211. The nick was located at base pair 2264 (39 nick) Extracts of human tumor cell lines having mutations in
or at position 1276 (59 nick), where 11 is the first transcribed base MSH6 are defective in repair of base-base mismatches
of the lacZ gene in M13mp2. Frameshift heteroduplexes contained
but retain some ability to repair insertion/deletion mis-1, 2, or 4 extra bases in the (2) strand, at nucleotides 91, 90±91, or
matches (Umar et al., 1994; Boyer et al., 1995; Drum-68±71, respectively. Reactions were incubated for 15 min. The re-
mond et al., 1995). However, unequivocally assigningsults are based on counting several hundred plaques per variable.
In all cases where repair was observed, the change in the ratio of the mismatch repair defect in these cells to the MSH6
blue to colorless plaques indicates that repair occurred in the strand mutation is made difficult by the fact that they are de-
containing the nick, which is known to serve as a strand-discrimina- rived from tumors and may contain mutations in other
tion signal in vitro.
genes. Extracts from mouse ES cells homozygous for
Msh6 mutations are ideally suited for ascertaining the
role of MSH6 in mismatch repair. Thus, extracts were
Msh6-related sequence on chromosome 4. Representa- prepared from the homozygous ES cell line MSH6-NH14
tive results of this analysis are shown in Figure 2B. We as well as from 1/1 and 1/2 cells. These were tested
examined a total of 333 mice from 49 litters. Of these, for their ability to repair substrates containing different
107 werewild-type, 142 were heterozygous, and 84were mismatches. Extracts prepared from Msh62/2 cells did
homozygous for the mutant allele. These results show not catalyze repair of a G-G mismatch in which the
that a mutation in the Msh6 gene is consistent with nick, which serves as the signal for strand specificity,
viability of the mice. is located either 39 or 59 to the mismatch (Figure 3).
Similarly, no repair of an A-C mismatch (39 nick) was
detected in an extract of 2/2 cells. In contrast, repair
Msh6 Mutant Cells Do Not Produce a Stable of these same substrates was observed in extracts of
Transcript or Protein both 1/1 cells and 1/2 cells. Extracts of all three cell
We ascertained if the mutantcells produced stable Msh6 types repaired substrates containing either 1, 2, or 4
transcripts. Total RNA from two double-targeted ES cell extra nucleotides in one strand (Figure 3). These data
lines was analyzed by Northern blotting with probe A show that MSH6 is required for strand-specific repair in
shown in Figure 2. Results of this analysis are shown in vitro of single base-base mismatches but is not essential
Figure 2C. The RNA from 1/1 ES cells contained a 4.4 for repair of insertion/deletion mismatches involving ei-
kb transcript. A similarly sized transcript, although at ther 1, 2, or 4 extra nucleotides.
reduced levels, was detectable in 1/2 cells, while no
transcript was detectable from Msh6 mutant cells. Msh62/2 Mice Have a Significantly
The nature of the mutation introduced into the Msh6 Reduced Life Span
locus and the lack of any detectable Msh6 message We examined the survival of animals that carry a muta-
from mutant ES cells suggested that they would not tion in the Msh6 gene. We maintained 33 wild-type, 40
have any MSH6 protein. To confirm these expectations, 1/2, and 28 2/2 animals in identical conditions and
we isolated total protein from the cells and analyzed it recorded the time when they became moribund or the
by Western blotting with an MSH6-specific antibody time of natural death. A summary of these observations
(Palombo et al., 1995). Results from this experiment are is presented in Figure 4. None of the three classes of
shown inFigure 2D. We were able to detect the expected mice died during the first 3 months of life. At 9 months
160 kDa protein in extracts from 1/1 and 1/2 cells but after birth, 97%±100% of the 1/1 and 1/2 animals were
alive, while only 60% of the 2/2 animals were alive. Bynot in 2/2 cells.
MSH6-Deficient Mice
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Figure 5. Tumors Observed in Msh6 Mutant
Mice
(A) A tumor of the small intestine (size bar 5
2 mm).
(B) Section of adenocarcinoma stained with
H, E, and an APC-specific antibody. Note the
brown color that represents APC protein ex-
pression and its lack (arrow) in the tumor (size
bar 5 80 mm).
(C) Mesenteric lymphoma (size bar 5 10 mm).
(D) Section of lymphoma stained with a B
cell±specific antibody (size bar 5 20 mm).
(E) Hepatoma (size bar 5 2 mm).
(F) Section of hepatoma stained with H and
E (size bar 5 40 mm).
12 months of age, 94% of the 1/1 and 90% of the 1/2 that was observed in two different 1/2 and one 2/2
mice was the presence of two aggressive tumor typesanimals were alive, while only 35% of the 2/2 animals
were alive. At 15 months of age, only 8% of the 2/2 adjacent to each other. This type of tumor, referred to
as a collision tumor, consisted of NHL and early invasivemice were alive, while more than 80% of the 1/2 and
1/1 mice were alive. These results suggest that lack of carcinoma of duodenum and jejunum. Gross examina-
tion of 14- to 16- month old 1/1 mice (n 5 10) did notMsh6 gene expression is not consistent with a normal
life span. It should be noted that the median survival reveal any tumors.
time of MSH2-deficient mice is 5±6 months (Reitmair et
al., 1996), in contrast to the 10 months median survival The Lymphomas Are Invasive and Are
of B- and T-Cell Origintime of MSH6-deficient mice.
We observed that among the 18 (5 1/2, 13 2/2) mice
that were examined, 2/13 homozygotes and 2/5 hetero-Msh6 Mutant Mice Develop a Spectrum
of Tumors zygotes had a significantly enlarged spleen. This en-
largement is due to the infiltration of the NHL. We alsoHeterozygous and homozygous Msh6 mutant mice were
examined for the development of tumors. We followed observed that the NHL was invasive in several of the
cases and was detected in the heart, liver, lung, thymus,the health of a total of 33 1/1, 40 1/2, and 28 2/2
mice. Over a 15 month period, 28 of 33 (85%) 1/1 and uterus, and several parts of the GI tract (Table 1).
To ascertain the cellular origin of the lymphomas, sec-31 of 40 (78%) 1/2 mice were healthy. We sacrificed 5
1/2 mice that became moribund and found them to tions of the tumors were stained with CD45R/B220, a B
cell±specific antibody and two CD3 antibodies that arebear easily identifiable tumor masses. Among the homo-
zygotes, 14 mice (50%) died prematurely and were not T cell±specific. Lymphomas from 4 1/2 and 8 2/2 mice
were examined by immunotyping. Of these, 9 were de-available for detailed analysis. 13 of the mice were sacri-
ficed because of morbidity. Of these, 12 had a spectrum termined to be B-cell lymphomas (Figure 5) that could
be classified into 3 diffuse large cleave, 3 non±largeof relatively large tumors in a number of different loca-
tions. One mouse, which is more than 15 months old, cleave, 1 immunoblastic, 1 large cleave±immunoblastic,
and 1 large cleave±mixed cell type. The other 3 wereis still alive. A representative sample of tumors that were
observed is shown in Figure 5, and the complete data T-cell lymphomas that were classified as lymphoblastic
lymphomas.are summarized in Table 1. In heterozygous mice that
had tumors, the most frequently found tumor was non-
Hodgkin's lymphoma (NHL) followed by tumors in the Tumors in Msh6 Mutant Mice Do Not Show
Microsatellite Instabilitygastrointestinal (GI) tract. In homozygous mice, the GI
tract tumors as well as the lymphomas were frequent. The microsatellite instability seen in tumors from HNPCC
patients appears to result from a failure to repair inser-In addition, these mice had tumors of the liver, lung,
skin, fibrous, and endothelial cells. An interesting feature tion/deletion mispairs, and such microsatellite instability
Cell
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Figure 6. Comparison of Microsatellite Instability in Tumors from
Mutant Msh6 and Mlh1 Mice
Tumor DNA was tested for microsatellite instability as described in
the Experimental Procedures.
(A) Test with marker JH104 a mononucleotide repeat marker located
in intron 1b of the Msh3 gene.
(B) Test with D7Mit91, a dinucleotide repeat marker. (WT), wild type
tail DNA. (T1)±(T3) refer to tumors. (*) shows an altered size band.
shows a high degree of correlation with the presense
of germline Msh2 and Mlh1 mutations that causedefects
in repair of insertion/deletion mispairs (Kolodner et al.,
1995; Kolodner, 1996; Liu et al., 1996; Modrich and
Lahue, 1996). Because repair of insertion/deletion mis-
pairs was observed in extracts from Msh62/2 cells, it
seemed likely that the Msh6 mutant tumor cells would
not show a high incidence of microsatellite instability.
To test this prediction, DNA from 12 different tumors
derived from 6 different mice was obtained and used
for PCR reactions with 8 different sets of PCR primers.
For comparison, we used tumors derived from mice
homozygous for Mlh1, another mismatch repair gene
(Edelmann et al., 1996). Four of these (D1MIT36, D7MIT91,
D14MIT15, and D18MIT15) primers amplify sequences
containing dinucleotide repeats, and the other four
(JH101, 102, 103 and 104) amplify sequences containing
mononucleotide repeats. The sizes of the alleles ampli-
fied by each of these markers in the 129/Ola and C57Bl/6
strain are known. Representative results are shown in
Figure 6. Testing of 4 separate tumors from Mlh1 mutant
mice with 5 different markers revealed microsatellite
instability of 45% with instability being observed at both
mono- and dinucleotide repeat loci. A similar test with
tumors from Msh6 mutant mice revealed 2/96 (2.1%)
instability, and the unstable loci observed were dinu-
cleotide repeat loci. Our results show that the tumors
present in Msh6 animals show little or no microsatellite
instability.
GI Tumors in Mutant Mice Do Not Have the
Adenomatous polyposis coli (APC) Protein
Mutations in the APC gene are responsible for FAP,
an inherited cancer predisposition syndrome character-
ized by progressive development of colonic polyps and
tumors and for a large number of sporadic colorectal
tumors. The tumors in HNPCC individuals also have
mutations in APC (Lazar et al., 1994; Huang et al., 1996),
suggesting that the hypermutability seen in these tu-
mors affects the APC gene. To assess if the GI tumors
seen inMsh6 mutant mice have a similar basis, we exam-
ined the tumors for the expression of the APC protein
using anti-APC antibodies. We examined 6 such tumors
in Msh62/2 mice. The APC protein was detected in the
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small intestine and at reduced levels in the crypt cells, also consistent with results obtained with a tumor cell
line that is mutant in both Msh6 and Msh3. Extracts ofwhile the tumor tissue had little or no detectable APC
protein (Figure 5). These results combined with the this cell line fail to repair base-base mismatches or 1-,
2-, and 4-nucleotide insertion/deletion mismatches (Ri-knowledge about the action of Msh6 suggest that muta-
tions in the Apc gene with a concomitant absence or singer et al., 1996). However, upon transfer of either
chromosome 2 encoding MSH2 and MSH6 or chromo-reduction of the APC protein may be causal in the devel-
opment of the GI tumors. Molecular biological tests are some 5 encoding MSH3, extracts from both MSH3 (2)
MSH6 (1) and MSH3 (1) MSH6 (2) cells repaired 1-, 2-,necessary to unambiguously address this issue.
and 4-nucleotide insertion/deletion mismatches, while
only the extract from MSH3 (2) MSH6 (1) cells repairedDiscussion
base-base mismatches (Umar et al., submitted). These
data support the view that the primary defect in Msh6Inactivation of the Mouse Msh6 Gene
mutant cells is the loss of the ability to repair base-baseTo examine the role of the mismatch repair gene, Msh6,
mispairs and that the mutations that accumulate in Msh6in normal growth and development, we generated mice
mutant mammalian cells should primarily be base sub-carrying a mutation in the Msh6 gene. Several lines of
stitution mutations.evidence show that we have inactivated the only func-
Cell lines that are exclusively defective in Msh6 havetional Msh6 gene in the mouse genome. Southern blot
not been described. The cell lines that we have gener-analysis of DNA from gene-targeted cells and mice de-
ated have such a defect and may prove to be valuablerived from them revealed that they contained thedesired
in assessing the status of the mismatch repair com-gene modification. Northern blot analysis revealed no
plexes in the absence of the MSH6 protein.Msh6 transcript in Msh62/2 cells and a reduced level of
message in Msh61/2 cells. Western blot analysis with
hMSH6 antibodies detected the expected 160 kDa pro- Msh6 Mutation Leads to Tumor Susceptibility
tein from Msh61/1 and 1/2 cell extracts, but no such Mutations in MSH6 have been observed in a small num-
protein was detectable in Msh62/2 cells. These results ber of human colonic tumor cell lines. However these
provide convincing evidence that the Msh6 gene was mutations have often been observed in conjunction with
functionally inactivated by the gene targeting event and mutations in other mismatch repair genes that could
that we have mice that are MSH6-deficient. conceivably contribute to or be the cause of the mutator
phenotype seen in these cell lines (da Costa et al., 1995;
Malkhosyan et al., 1996; Risinger et al., 1996). AlthoughExtracts of Msh62/2 Cells Cannot Repair
Base-Base Mismatches in DNA Drummond et al. (1995) suggested that mutations in
MSH6 may result in hypermutability and a predispositionExtracts of Msh62/2 ES cells were completely defective
in their ability to repair base-base mismatches that are to cancer, no germline mutations in MSH6 have been
observed in HNPCC families (Liu et al., 1996; Peltomakirepaired in 1/1 and 1/2 extracts (Figure 3). This is
consistent with a model in which MSH6 partners with et al., 1997). These data suggested that MSH6 may play
little if any role in tumor suppression. The studies pre-MSH2 to form a heterodimer that recognizes and binds
to single base-base mismatches to initiate repair (Drum- sented here show that mice lacking MSH6 have a predis-
position to develop lymphomas and a number of othermond et al., 1995). The ability of the 2/2 extract to repair
1, 2, and 4 nucleotide insertion/deletion mismatches tumors.
Based upon the mutator phenotype seen in Msh6 mu-(Figure 3) is consistent with the existence of a second
mispair recognition complex in these cells that is either tants and the proposed mispair recognition properties
of the MSH2±MSH6 complex, absence of the gene prod-solely responsible for recognition of insertion/deletion
mispairs or partially redundant with the MHS2±MSH6 uct is expected to lead to accumulation of point muta-
tions (Marsischky et al., 1996). When the appropriatecomplex for recognition of insertion/deletion mispairs.
Based on the analysis of the Msh2, Msh3, and Msh6 target genes are mutated, the resulting mutant cells
would be expected to enter a proliferative pathway.genes and gene products in yeast and human systems,
this other complex is likely to consist of the MSH2 and Based upon this notion, lack of MSH6 would be ex-
pected to lead to reduced life span and tumorigenicityMSH3 proteins (Drummond et al., 1995; Acharya et al.,
1996; Habraken et al., 1996; Johnson et al., 1996; Mar- of a number of different cell types. Both of these expec-
tations are realized in Msh6 mutant mice. The precisesischky et al., 1996; Palombo et al., 1996; Sia et al.,
1997). The in vitro mismatch repair defects we have targets for mutations for the development of lymphomas
in Msh6 mice are not known. It is of interest, however,observed in our analysis of Msh6 mutant extracts is
exactly as predicted from the analysis of the mutator to note that lymphomas are also a predominant early
tumor in Msh2 mutant mice (Reitmair et al., 1996). Ourphenotypes caused by Msh6 mutations in yeast (Mar-
sischky et al., 1996; Sia et al., 1997). It is also consistent analysis of the colonic tumors that develop in the Msh6
mutant mice shows that they have lost APC expression.with the observation of a lack of dinucleotide repeat
instability and reduced mononucleotide repeat instabil- APC gene mutations have been implicated in FAP and
in sporadic colorectal tumors and colorectal tumors inity in Msh6 mutant tumor cell lines and the lack of either
mononucleotide repeat or dinucleotide repair instability HNPCC patients, leading to the proposal that the aquisi-
tion of APC gene mutations plays an important earlyin the tumors from Msh6 mutant mice (Bhattacharyya
et al., 1994; Shibata et al., 1994; Papadopoulos et al., step in the development of these tumors. It is attractive
to propose that mutation of the Apc gene due to the1995). The mismatch repair activity data in Figure 3 are
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mutator phenotype caused by Msh6 mutations also with mutations in a member of the Mlh gene family (Mlh1
plays an important role in the development of the GI and Pms2) are now available. MSH2- and MSH6-defi-
tumors we observed. cient mice are viable and fertile and show a cancer
Mutations in another mismatch repair gene, Msh2, predisposition phenotype (Reitmair et al., 1995, 1996;
also leads to early lymphomas and colonic tumors later present work). The Mlh1 and Pms2 mice are also viable
in the lives of mice. MSH2 mutations are common in in the homozygous state and show a predisposition to
HNPCC patients (Liu et al., 1996; Peltomaki et al., 1997). cancer but have varying degrees of sterility (Baker et
Therefore, it is reasonable to ask why germline muta- al., 1995, 1996; Edelmann et al., 1996). The PMS2 males
tions in MSH6 were not detected in HNPCC families. are sterile, while the females are normal. Both males
There are two possible explanations for this. Much of the and females deficient in MLH1 are sterile. In both cases,
attention on HNPCC families has been focused on those the sterility is the result of meiotic abnormalities. Based
whose tumors show a replication error (RER1) pheno- on our results with Mlh1-deficient mice (Edelmann et
type as detected by microsatellite instability because al., 1996), we suggested that in meiosis, Msh2 might be
many HNPCC families show this phenotype (Aaltonen replaced by another member of the Msh gene family.
et al., 1993; Lindblom et al., 1993). Such microsatellite The fact that MSH6-deficient mice are fertile suggests
instability appears to result from failure to repair inser- that Msh6 is dispensable in meiosis. It will now be of
tion/deletion mispairs, a type of repair that does not importance to ascertain if other members of the Msh
require MSH6 (Marsischky et al., 1996; Johnson et al., gene family function in meiosis by determining if muta-
1996; Sia et al., 1997). Thus, the selection of such RER1 tions in these genes cause the same types of meiotic
HNPCC families would be expected to exclude from phenotypes as Pms2 or Mlh1 mutations.
analysis those families that have germline MSH6 muta-
tions. Alternately, the mutator phenotype caused by
Experimental ProceduresMSH6 mutations is quite different from the mutator phe-
notype caused by MSH2 or MLH1 mutations, and it is Isolation and Characterization of the Mouse Msh6 Gene
possible that the MSH6 mutator phenotype does not The isolation and characterization of mouse Msh6 cDNA clones,
result in the inactivation of the target genes required 59-RACE products, and P1 clones containing the Msh6 genomic
for cancer predisposition. Our results demonstrate that region has been performed essentially as described in previous
studies (Fishel et al., 1993; Bronner et al., 1994; Kolodner and AlaniMSH6 germline mutations result in cancer susceptibility,
1994; Kolodner et al., 1995). Degenerate PCR was first used to isolatesupporting the view that HNPCC or other families having
a portion of the mouse Msh6 coding sequence. Specifically, primedMSH6 germline mutations could have been excluded
cDNA was first made from 3T3 RNA using the degenerate primerfrom analysis by selection of those with an RER1 pheno-
59-IGTICCIC(T/G)ICCIAI(T/C)TC(G/A)TC and Superscript RT (Life
type. We predict that HNPCC families that do not show Technologies). This cDNA and primer were then used in PCR re-
an RER1 phenotype or other types of families that have actions with Taq DNA polymerase and a second degenerate PCR
a predisposition to lymphomas as well as GI tumors are primer, 59-IGGICCIAA(C/T)ATGGGIGGIAA, and the resulting PCR
product was cloned into the EcoRV site of pBluescript SK(1) andexcellent candidates for having germline mutations in
sequenced. A hybridization probe made using the resulting partialthe MSH6 gene. Efforts to identify such families are
Msh6 clone was used to screen a mouse pre-B cell, size-selectedunderway.
cDNA library in the lambda gt10 vector, and 26 positives were ob-
tained. Clones containing the longest inserts were identified by PCR
Roles of MSH6 and MSH3 with primers 20322 59-TTGAGCAAGTTCAGCCTGG and 20068 59-
Based on the phenotypes observed in yeast and based CTTATGAGTATTTCTTCCAGG, and the PCR product corresponding
to the longest insert was sequenced. Additional 59 sequence wason in vitro interactions involving MSH3 and MSH6, it
then obtained using 59 RACE using mouse spleen double-strandedhas been suggested that these two proteins would be
cDNA containing a 59 adaptor (Clonetech), primer 59-CCATCCTAATcapable of substituting for each other and that a double
ACGACTCACTATAGGGC matching the 59 adaptor, and a Msh6-mutant of Msh3 and Msh6 is required to elicit a pheno-
specific primer 59-GCCGGCTGCTTCGCCTAGGCCCCTG derived
type that would be equivalent to the knockout of Msh2 from the 59 end of the cDNA sequence. The resulting RACE product
(Johnson et al., 1996; Marsischky et al., 1996; Sia et al., was cloned into the EcoRV site of pBluescript SK(1) and sequenced.
1997). Experimental results described here show that P1 genomic clones containing the Msh6 gene were obtained by
screening a mouse 129 P1 library (Genome Systems) using primersthe absence of MSH6 cannot be fully compensated by
23038 59-GAGTCCGGTCTTCCGAGCC and 23041 59-GTACGAAGMSH3 because Msh6 mutations clearly predispose mice
AAACGACATACAGC and 2 clones (numbers 8229 and 8230) wereto the development of cancer. The fact that Msh6 mutant
obtained. The intron-exon junctions, all of the exons, and many ofmice have a longer life span than Msh2 mutant mice
the introns were sequenced directly from P1 DNA isolated from a
and that they develop tumors somewhat later in life may Cre2 host strain with primers derived from the coding and intron
suggest a small compensatory role for Msh3. A better sequences using proceedures provided by Genome Systems essen-
understanding of the relative roles of Msh3 and Msh6 tially as previously described. All DNA sequencing was performed
with an ABI/Perkin Elmer 373 sequencer and dye terminator chemis-would require development of mice that lack Msh3. We
try and contigs were constructed with Sequencher software.have generated such mice and are examining thepheno-
types caused by Msh3 mutations by themselves and in
combination with Msh6 mutations. Such mice might also Construction of the pMSH6 Targeting Vectors
A genomic Msh6 fragment containing the exons 2, 3, and a portionhelp us to better understand the relative roles of MSH3
of exon 4 was obtained by screening a mouse genomic Charon 35,and MSH6 in mammalian mismatch repair.
129/Ola phage library with a full-length mouse Msh6 cDNA probe.
A 7.5 kb SalI fragment was subcloned into pUC19, and the intron-Different Mismatch Repair Genes Play exon structure of part of the gene was determined using sequencing
Different Roles in Mice and restriction mapping (Figure 1). A 1.7 kb XhoI±HindIII PGKneo
Two sets of mice with mutations in a member of the was blunted with Klenow polymerase and cloned into the Eco47III
site at codon 336 in exon 4. Finally, a 1.1 kb XhoI±BamHI fragmentMsh gene family (Msh2 and Msh6) and two sets of mice
MSH6-Deficient Mice
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from pMC1tk (Mansour et al., 1988) was treated with Klenow poly- The reaction products were processed and introduced into E. coli
NR9162 (mutS), and plaque colors were determined. Repair effi-merase and cloned into the single SmaI restriction site located 39
to exon 4. The resulting gene targeting clone was designated ciency is expressed in percent as 100 3 (1 2 the ratio of the percent-
ages of mixed bursts obtained from extract-treated and untreatedpMSH6NTK. The targeting vector pMSH6HTK used for the genera-
tion of double knockout ES cell lines was identical to pMSH6NTK samples).
except that a 2.0 kb ClaI±XhoI pGKhygro fragment was cloned into
the Eco47III site. Analysis of Tumors
Animals were sacrificed by neck dislocation. Tumors, if found, and
Electroporation of Embryonic Stem Cells the gastrointestinal tract and other organs including the lungs, heart,
The targeting vector pMSH6NTK (40 mg) was linearized at the single liver, kidneys, and spleen were removed and fixed in 10% neutral
Sse8387I site and electroporated into 2.0 3 107 WW6 embryonic buffered formalin. The gastrointestinal tract was opened and exam-
stem cells (Ioffe et al., 1995) and selected with G418 (150 mg/ml) ined under a dissecting microscope for tumors. Representative tis-
and ganciclovir (2 mM) as described previously (Sirotkin et al., 1995). sues from the tumors and organs were taken for processing and
Colonies were picked after 10 days and their DNA was screened paraffin embedding. All tissue sections were prepared for Hematox-
by PCR using forward primer A 59-TGGAAGGATTGGAGCTACGG-39 ylin and Eosin stain. Tumor tissues were studied for APC protein
and reverse primer B 59-AGGGCGTATGGCAAGTATCC-39. The reac- expression and lymphoma immunotyping. The antibodies used in
tion was performed in a 50 ml reaction mixture containing 100 ng this study include the APC proteins C-20 and N-15 (Santa Cruz),
of DNA, 5 ng/ml of each primer, 1.5 mM MgCl2, 0.2 mM of each B lymphocyte CD45R/B220 (Pharmingen), and T lymphocyte CD3
dNTP, and 0.5 U of Taq polymerase. Cycling conditions were: 5 min (Vector and Zymed).
at 948C (1 cycle), 1 min at 948C, 1 min at 578C, 1.5 min at 728C
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GenBank Accession Numbers
The genomic sequences defining the Msh6 gene structure and cod-
ing sequences have been deposited in GenBank under accession
numbers AF031085, AF031086, and AF031087.
Note Added in Proof
As predicted from the work described here, a germline mutation in
the human MSH6 gene was detected in affected members of a
family with atypical HNPCC (Akiyama et al., 1997, in Cancer Res. 57,
3920±3923). We have also detected a germline nonsense mutation in
exon 4 of a HNPCC patient from a family meeting the Amsterdam
Criteria whose tumors showed low mononucleotide repeat instabil-
ity and no dinucleotide repeat instability. We are currently analyzing
additional candidate HNPCC families for the presence of germline
hMSH6 mutations.
